SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-074174
Filing Date
2021-05-28
Accepted
2021-05-28 16:15:57
Documents
12
Period of Report
2021-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2116866d11_6k.htm 6-K 16072
2 EXHIBIT 1.1 tm2116866d11_ex1-1.htm EX-1.1 230726
3 EXHIBIT 1.2 tm2116866d11_ex1-2.htm EX-1.2 74699
4 EXHIBIT 1.3 tm2116866d11_ex1-3.htm EX-1.3 114034
5 EXHIBIT 4.1 tm2116866d11_ex4-1.htm EX-4.1 637573
6 EXHIBIT 4.2 tm2116866d11_ex4-2.htm EX-4.2 711099
7 EXHIBIT 4.3 tm2116866d11_ex4-3.htm EX-4.3 360597
8 EXHIBIT 4.4 tm2116866d11_ex4-4.htm EX-4.4 1059203
9 EXHIBIT 5.1 tm2116866d11_ex5-1.htm EX-5.1 78411
10 EXHIBIT 5.2 tm2116866d11_ex5-2.htm EX-5.2 36280
11 GRAPHIC tm2116866d11_ex5-1img01.jpg GRAPHIC 8976
12 GRAPHIC tm2116866d11_ex5-2img01.jpg GRAPHIC 10936
  Complete submission text file 0001104659-21-074174.txt   3347612
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-11960 | Film No.: 21980389
SIC: 2834 Pharmaceutical Preparations